novo nordisk oral semaglutide Hims & Hers makes deal with in obesity strategy shift Novo Nordisk secures EMA approval

Safe and vegetarian, suitable for long-term daily use

Rahman OF, Lee SJ, Seeds WA

These include: Severe headaches , particularly if sudden-onset or different from usual patterns Visual disturbances such as blurred vision or seeing spots Chest pain or pressure , which may indicate cardiovascular complications (call 911) Shortness of breath or difficulty breathing, especially with exertion (call 911 if severe) Neurological symptoms including facial drooping, arm weakness, speech difficulties (call 911) Severe dizziness or lightheadedness , particularly upon standing (suggesting hypotension) Nosebleeds that are difficult to control Confusion or difficulty concentrating Patients should also promptly report semaglutide-specific concerns that may require immediate evaluation: Severe, persistent abdominal pain (possible pancreatitis) Right upper quadrant pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Signs of allergic reaction including rash, swelling, or difficulty breathing New or worsening vision problems (potential diabetic retinopathy complications) Persistent nausea, vomiting, or diarrhea can lead to dehydration, electrolyte imbalances, and secondary blood pressure changes

Your clinician will work closely with you to determine the medication that suits you best

You can start the conversation by expressing your interest in exploring new treatment options and mentioning that you've been reading about GLP-1 therapy

Rapamycin-Induced Apoptosis in HGF-Stimulated Lens Epithelial Cells by AKT/mTOR, ERK and JAK2/STAT3 Pathways